Immunization, HepB3 in Sub-Saharan Africa
Sub-Saharan Africa: Immunization, HepB3 was 74.0% in 2024. ◆ Volatile
Immunization, HepB3 in Sub-Saharan Africa, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
In 2024, immunization, hepb3 in Sub-Saharan Africa stood at 74.0%.
Compared with earlier readings it is up 0.1% on the previous year and up 5.5% over ten years.
Over the whole period, immunization, hepb3 in Sub-Saharan Africa peaked at 76.3% in 2019 and was at its lowest, 0.0%, in 1985.
That places Sub-Saharan Africa 41st out of 47 groups with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Sub-Saharan Africa, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 0.2% | — |
| 1992 | 0.0% | -100.0% |
| 1993 | 0.1% | — |
| 1994 | 0.1% | +2.0% |
| 1995 | 0.4% | +181.0% |
| 1996 | 0.6% | +53.6% |
| 1997 | 4.3% | +649.9% |
| 1998 | 4.2% | -1.1% |
| 1999 | 4.1% | -2.1% |
| 2000 | 4.8% | +15.2% |
| 2001 | 5.5% | +15.3% |
| 2002 | 23.2% | +322.0% |
| 2003 | 26.8% | +15.5% |
| 2004 | 31.2% | +16.4% |
| 2005 | 38.8% | +24.3% |
| 2006 | 44.5% | +14.8% |
| 2007 | 61.3% | +37.7% |
| 2008 | 65.2% | +6.3% |
| 2009 | 70.5% | +8.1% |
| 2010 | 68.3% | -3.2% |
| 2011 | 68.9% | +1.0% |
| 2012 | 68.6% | -0.5% |
| 2013 | 68.3% | -0.4% |
| 2014 | 70.1% | +2.7% |
| 2015 | 70.2% | +0.1% |
| 2016 | 73.1% | +4.2% |
| 2017 | 73.6% | +0.6% |
| 2018 | 75.0% | +1.9% |
| 2019 | 76.3% | +1.8% |
| 2020 | 73.7% | -3.5% |
| 2021 | 72.7% | -1.3% |
| 2022 | 72.7% | -0.0% |
| 2023 | 73.9% | +1.6% |
| 2024 | 74.0% | +0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 1.4% | 0.0% | 4.3% | 10 |
| 2000s | 37.2% | 4.8% | 70.5% | 10 |
| 2010s | 71.2% | 68.3% | 76.3% | 10 |
| 2020s | 73.4% | 72.7% | 74.0% | 5 |
Countries ranked near Sub-Saharan Africa
More health data for Sub-Saharan Africa
- Population ages 65-69, female, annual growth rate 3.61 % change on previous year (2025)
- Population ages 55-59, male, per capita 0.0114 units per person (2025)
- Population ages 60-64, female, annual growth rate 3.05 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0099 units per person (2025)
- Population ages 60-64, male, annual growth rate 3.35 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0086 units per person (2025)
- Population ages 65-69, male, per capita 0.0062 units per person (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hepb3 in Sub-Saharan Africa?
- Immunization, hepb3 in Sub-Saharan Africa was 74.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Sub-Saharan Africa?
- The highest recorded value was 76.3% in 2019.
- What is the lowest immunization, hepb3 recorded in Sub-Saharan Africa?
- The lowest recorded value was 0.0% in 1985.
- How does Sub-Saharan Africa rank for immunization, hepb3?
- Sub-Saharan Africa ranks 41st out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Sub-Saharan Africa?
- Over the last ten years it is up 5.5%. The long-run trend across the full record is volatile.
- Where does this Sub-Saharan Africa data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.